GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blueberries Medical Corp (STU:1OA) » Definitions » Gross Margin %

Blueberries Medical (STU:1OA) Gross Margin % : 21.05% (As of Sep. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Blueberries Medical Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Blueberries Medical's Gross Profit for the three months ended in Sep. 2023 was €0.01 Mil. Blueberries Medical's Revenue for the three months ended in Sep. 2023 was €0.06 Mil. Therefore, Blueberries Medical's Gross Margin % for the quarter that ended in Sep. 2023 was 21.05%.


The historical rank and industry rank for Blueberries Medical's Gross Margin % or its related term are showing as below:

STU:1OA' s Gross Margin % Range Over the Past 10 Years
Min: -176.26   Med: -7.66   Max: 93.94
Current: 38.6


During the past 10 years, the highest Gross Margin % of Blueberries Medical was 93.94%. The lowest was -176.26%. And the median was -7.66%.

STU:1OA's Gross Margin % is ranked worse than
65.25% of 990 companies
in the Drug Manufacturers industry
Industry Median: 46.705 vs STU:1OA: 38.60

Blueberries Medical had a gross margin of 21.05% for the quarter that ended in Sep. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Blueberries Medical was 0.00% per year.


Blueberries Medical Gross Margin % Historical Data

The historical data trend for Blueberries Medical's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blueberries Medical Gross Margin % Chart

Blueberries Medical Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 95.24 -176.04 -7.98

Blueberries Medical Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.75 130.00 -15.09 42.55 21.05

Competitive Comparison of Blueberries Medical's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Blueberries Medical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blueberries Medical's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Blueberries Medical's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Blueberries Medical's Gross Margin % falls into.



Blueberries Medical Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Blueberries Medical's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=-0 / 0.163
=(Revenue - Cost of Goods Sold) / Revenue
=(0.163 - 0.176) / 0.163
=-7.98 %

Blueberries Medical's Gross Margin for the quarter that ended in Sep. 2023 is calculated as


Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=0 / 0.057
=(Revenue - Cost of Goods Sold) / Revenue
=(0.057 - 0.045) / 0.057
=21.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Blueberries Medical  (STU:1OA) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Blueberries Medical had a gross margin of 21.05% for the quarter that ended in Sep. 2023 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Blueberries Medical Gross Margin % Related Terms

Thank you for viewing the detailed overview of Blueberries Medical's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Blueberries Medical (STU:1OA) Business Description

Traded in Other Exchanges
Address
8500 West Georgia Street, Suite 2200, Vancouve, BC, CAN, V6C 3E8
Blueberries Medical Corp is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. It cultivates, produces, and distributes cannabidiol (CBD) and THC (tetrahydrocannabinol) based medical cannabis domestically as well as internationally. It generates all of its revenues from Colombia.

Blueberries Medical (STU:1OA) Headlines

No Headlines